Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Canadian Bio gets Taken Out by BP

<< Previous

Bullboard Posts

Next >>

Comment by inthnoon Mar 19, 2024 10:40am

110 Views

Post# 35940491

RE:RE:Canadian Bio gets Taken Out by BP

The company was trading around a billion dollar cap for the last 3 months before the offer came through so would be nice if we could get a nice steady rise leading into any possible BO or partnership. Still hoping and thinking that they want this done by the AGM but at the same time BP might be waiting for that inflection point which could be OS for the mbc for example.

<< Previous

Bullboard Posts

Next >>

Advancing flagship Ishkõday Gold Project in Ontario